Prosecution Insights
Last updated: August 18, 2026

Kashiv Biosciences LLC

11 pending office actions • 8 art units • 8 examiners • 0 of 11 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
6
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (45%)
6
Medium (55%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (36%)
§102 only1 (9%)
Double-patenting + other1 (9%)
Multi-statute (no §101)5 (45%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MCDERMOTT, JEANNIE 3 59.9% +15.6%
HAQ, SHAFIQUL 2 65.0% +55.1%
REGLAS, GEORGIANA C 1 37.5% +31.1%
NOGUEROLA, ALEXANDER STEPHAN 1 82.7% +2.9%
ROBINSON, HOPE A 1 67.6% +43.3%
EDWARDS, JESSICA FAYE 1 39.1% +46.4%
CORNET, JEAN P 1 42.1% +47.5%
TAYLOR, LIA ELAN 1 64.5% +29.0%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19230889 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE 35d overdue
19230884 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE 32d overdue
17682314 FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY TAYLOR, LIA ELAN 5d overdue
18720877 AN IMPROVED METHOD FOR SEPARATION OF LOW MOLECULAR WEIGHT PROTEINS NOGUEROLA, ALEXANDER STEPHAN 9d
17922734 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18125616 IMPROVED PROCESS FOR THE SEPARATION AND ANALYSIS OF PANCREATIC ENZYMES EDWARDS, JESSICA FAYE 157d overdue
19230889 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE 35d overdue
19230884 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE 32d overdue
18262318 METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE ROBINSON, HOPE A 24d overdue
17682314 FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY TAYLOR, LIA ELAN 5d overdue
18620441 PROCESS FOR PURIFICATION OF PROTEIN HAQ, SHAFIQUL 36d
19432924 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN REGLAS, GEORGIANA C
18620649 PROCESS FOR PURIFICATION OF PROTEIN HAQ, SHAFIQUL

Top Art Units

Art UnitApps
1777 3
1678 2
1651 1
1795 1
1652 1
1657 1
1628 1
1641 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19432924 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN REGLAS, GEORGIANA C 1651 §102 Final Rejection Pending Dec 24, 2025
19230889 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE 1777 §103§112Other Non-Final OA 35d overdue Pending Jun 06, 2025
19230884 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE 1777 §103§112Other Non-Final OA 32d overdue Pending Jun 06, 2025
18720877 AN IMPROVED METHOD FOR SEPARATION OF LOW MOLECULAR WEIGHT PROTEINS NOGUEROLA, ALEXANDER STEPHAN 1795 §103§112 Non-Final OA 9d Pending Jun 17, 2024
18620649 PROCESS FOR PURIFICATION OF PROTEIN HAQ, SHAFIQUL 1678 §103 Final Rejection Pending Mar 28, 2024
18620441 PROCESS FOR PURIFICATION OF PROTEIN HAQ, SHAFIQUL 1678 §103Other Non-Final OA 36d Pending Mar 28, 2024
18262318 METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE ROBINSON, HOPE A 1652 §103 Final Rejection 24d overdue Pending Jul 20, 2023
18125616 IMPROVED PROCESS FOR THE SEPARATION AND ANALYSIS OF PANCREATIC ENZYMES EDWARDS, JESSICA FAYE 1657 §103 Final Rejection 157d overdue Pending Mar 23, 2023
17922734 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN MCDERMOTT, JEANNIE 1777 §103§112 Final Rejection Pending Nov 01, 2022
17779015 PRODRUGS OF FULVESTRANT CORNET, JEAN P 1628 §103§112DPOther Non-Final OA Pending May 23, 2022
17682314 FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY TAYLOR, LIA ELAN 1641 §102§103Other Non-Final OA 5d overdue Pending Feb 28, 2022

Managing Kashiv Biosciences LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month